CLSS-based assessment of alfa-adrenoceptor blockers for male LUTS (CLAM-STUDY).
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2013
At a glance
- Drugs Silodosin (Primary) ; Tamsulosin (Primary)
- Indications Lower urinary tract symptoms
- Focus Therapeutic Use
- Acronyms CLAM-STUDY
- 01 Feb 2013 Planned end date 31 Dec 2013 added as reported by University Hospital Medical Information Network - Japan.
- 10 Feb 2010 New trial record